Sydney Blood Cancer Research Institute
About Support
Donate
News Research Programs New Research Clinical Trials Publications
Trivia Night 2022 Trivia Night 2024 move4myeloma Bloodraiser Pat Faga Charity Ball 2023 Charity Night Showcase Webinar Craig Pin Golf Day Charity Launch Patrons Tributes
About Research News Research Programs New Research Clinical Trials Publications Support Events & Sponsors Trivia Night 2022 Trivia Night 2024 move4myeloma Bloodraiser Pat Faga Charity Ball 2023 Charity Night Showcase Webinar Craig Pin Golf Day Charity Launch Patrons Tributes
Sydney Blood Cancer Research Institute
Donate
Blood Cancer Immune Therapy Team (BITT)
Blood Cancer Immune Therapy Team (BITT)
Donna FrancisFebruary 2, 2021
Mutation burden in patients with haematological malignancies
Mutation burden in patients with haematological malignancies
Donna FrancisDecember 4, 2019
Improve the utility of multiparameter flow cytometry (MFC) for clinical diagnosis
Improve the utility of multiparameter flow cytometry (MFC) for clinical diagnosis
Donna FrancisDecember 4, 2019
Getting Chimeric Antigen Receptor (CAR)-T Cell Therapy to Sydney
Getting Chimeric Antigen Receptor (CAR)-T Cell Therapy to Sydney
Donna FrancisDecember 4, 2019
Antibodies-based immunotherapy in multiple myeloma
Antibodies-based immunotherapy in multiple myeloma
Donna FrancisDecember 4, 2019
“Bona fide” attributes of T cells function in MGUS and dysfunction in multiple myeloma
“Bona fide” attributes of T cells function in MGUS and dysfunction in multiple myeloma
Donna FrancisDecember 4, 2019

Contact US

Privacy

Terms

©2019 SYDNEY BLOOD CANCER RESEARCH

Icons made by Freepic